Classifications

• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
  • A61K31/425—Thiazoles
  • A61K31/426—1,3-Thiazoles
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D417/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00
  • C07D417/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and sulfur atoms as the only ring hetero atoms, not provided for by group C07D415/00 containing three or more hetero rings
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/535—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with at least one nitrogen and one oxygen as the ring hetero atoms, e.g. 1,2-oxazines
  • A61K31/5375—1,4-Oxazines, e.g. morpholine
  • A61K31/5377—1,4-Oxazines, e.g. morpholine not condensed and containing further heterocyclic rings, e.g. timolol
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/40—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil
  • A61K31/403—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with one nitrogen as the only ring hetero atom, e.g. sulpiride, succinimide, tolmetin, buflomedil condensed with carbocyclic rings, e.g. carbazole
  • A61K31/404—Indoles, e.g. pindolol
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/41—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having five-membered rings with two or more ring hetero atoms, at least one of which being nitrogen, e.g. tetrazole
  • A61K31/425—Thiazoles
  • A61K31/427—Thiazoles not condensed and containing further heterocyclic rings
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/495—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with two or more nitrogen atoms as the only ring heteroatoms, e.g. piperazine or tetrazines
  • A61K31/505—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim
  • A61K31/517—Pyrimidines; Hydrogenated pyrimidines, e.g. trimethoprim ortho- or peri-condensed with carbocyclic ring systems, e.g. quinazoline, perimidine
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K45/00—Medicinal preparations containing active ingredients not provided for in groups A61K31/00 - A61K41/00
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P11/00—Drugs for disorders of the respiratory system
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P35/00—Antineoplastic agents
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
  • A61P43/00—Drugs for specific purposes, not provided for in groups A61P1/00-A61P41/00
• • C—CHEMISTRY; METALLURGY
  • C07—ORGANIC CHEMISTRY
  • C07D—HETEROCYCLIC COMPOUNDS
  • C07D413/00—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms
  • C07D413/14—Heterocyclic compounds containing two or more hetero rings, at least one ring having nitrogen and oxygen atoms as the only ring hetero atoms containing three or more hetero rings
• • A—HUMAN NECESSITIES
  • A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
  • A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
  • A61K31/00—Medicinal preparations containing organic active ingredients
  • A61K31/33—Heterocyclic compounds
  • A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
  • A61K31/435—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having six-membered rings with one nitrogen as the only ring hetero atom
  • A61K31/47—Quinolines; Isoquinolines

Landscapes

• Health & Medical Sciences (AREA)
• Chemical & Material Sciences (AREA)
• Animal Behavior & Ethology (AREA)
• Veterinary Medicine (AREA)
• Public Health (AREA)
• Medicinal Chemistry (AREA)
• General Health & Medical Sciences (AREA)
• Pharmacology & Pharmacy (AREA)
• Life Sciences & Earth Sciences (AREA)
• Organic Chemistry (AREA)
• Epidemiology (AREA)
• General Chemical & Material Sciences (AREA)
• Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
• Chemical Kinetics & Catalysis (AREA)
• Engineering & Computer Science (AREA)
• Bioinformatics & Cheminformatics (AREA)
• Pulmonology (AREA)
• Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
• Plural Heterocyclic Compounds (AREA)
• Medicines That Contain Protein Lipid Enzymes And Other Medicines (AREA)
• Nitrogen And Oxygen Or Sulfur-Condensed Heterocyclic Ring Systems (AREA)

Applications Claiming Priority (1)

Publications (1)

Family

ID=55299545

Family Applications (1)

Country Status (40)

Families Citing this family (1)

Family Cites Families (10)

• 2015
  • 2015-07-31 FR FR1557412A patent/FR3039401B1/en not_active Expired - Fee Related
• 2016
  • 2016-07-11 SG SG10201605664SA patent/SG10201605664SA/en unknown
  • 2016-07-11 PH PH12016000248A patent/PH12016000248A1/en unknown
  • 2016-07-20 AU AU2016206300A patent/AU2016206300A1/en not_active Abandoned
  • 2016-07-21 CA CA2936904A patent/CA2936904C/en not_active Expired - Fee Related
  • 2016-07-26 US US15/219,691 patent/US20170027952A1/en not_active Abandoned
  • 2016-07-27 BR BR102016017404A patent/BR102016017404A2/en not_active IP Right Cessation
  • 2016-07-27 MX MX2016009743A patent/MX366748B/en active IP Right Grant
  • 2016-07-28 KR KR1020160096116A patent/KR101822492B1/en not_active Expired - Fee Related
  • 2016-07-28 CN CN201610603485.2A patent/CN106397427A/en active Pending
  • 2016-07-29 LT LTEP16181821.6T patent/LT3124025T/en unknown
  • 2016-07-29 ME MEP-2018-75A patent/ME03052B/en unknown
  • 2016-07-29 MD MDE20170007T patent/MD3124025T2/en not_active IP Right Cessation
  • 2016-07-29 MA MA39693A patent/MA39693B1/en unknown
  • 2016-07-29 JP JP2016149874A patent/JP2017061445A/en active Pending
  • 2016-07-29 SI SI201630028T patent/SI3124025T1/en unknown
  • 2016-07-29 TN TNP/2018/000028A patent/TN2018000028A1/en unknown
  • 2016-07-29 EP EP16181821.6A patent/EP3124025B1/en active Active
  • 2016-07-29 PT PT161818216T patent/PT3124025T/en unknown
  • 2016-07-29 DK DK16181821.6T patent/DK3124025T3/en active
  • 2016-07-29 WO PCT/FR2016/051976 patent/WO2017021634A1/en not_active Ceased
  • 2016-07-29 TW TW105124215A patent/TWI623315B/en not_active IP Right Cessation
  • 2016-07-29 RS RS20180362A patent/RS57057B1/en unknown
  • 2016-07-29 PE PE2018000094A patent/PE20190350A1/en unknown
  • 2016-07-29 ES ES16181821.6T patent/ES2671133T3/en active Active
  • 2016-07-29 EA EA201600507A patent/EA032217B1/en not_active IP Right Cessation
  • 2016-07-29 NO NO16181821A patent/NO3124025T3/no unknown
  • 2016-07-29 HU HUE16181821A patent/HUE037632T2/en unknown
  • 2016-07-29 CR CR20180044A patent/CR20180044A/en unknown
  • 2016-07-29 CU CUP2018000013A patent/CU20180013A7/en unknown
  • 2016-07-29 AR ARP160102311A patent/AR105527A1/en unknown
  • 2016-07-29 RU RU2016131395A patent/RU2695362C2/en not_active IP Right Cessation
  • 2016-07-29 PL PL16181821T patent/PL3124025T3/en unknown
• 2018
  • 2018-01-17 SV SV2018005615A patent/SV2018005615A/en unknown
  • 2018-01-18 EC ECIEPI20183671A patent/ECSP18003671A/en unknown
  • 2018-01-29 CL CL2018000256A patent/CL2018000256A1/en unknown
  • 2018-01-30 IL IL257232A patent/IL257232A/en unknown
  • 2018-01-30 CO CONC2018/0000953A patent/CO2018000953A2/en unknown
  • 2018-05-15 CY CY181100494T patent/CY1120792T1/en unknown
  • 2018-05-16 HR HRP20180760TT patent/HRP20180760T1/en unknown
• 2019
  • 2019-05-27 JP JP2019098506A patent/JP2019163306A/en not_active Ceased

Also Published As

Similar Documents